Rocket Pharmaceuticals Inc
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -100.0% | – | – | – | -100.0% | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | +3.9% | +14.3% | +298.1% | -59.1% | +20.3% | +4.4% | +8.7% | -5.9% | +2.9% | +2.3% | +192.8% | -56.3% | +3.8% | +2.1% | – | – | -15.1% | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -143.7% | – | – | – | -165.1% | – | – | – | – | – | – | |
| – | +12.9% | -25.2% | -48.9% | -22.2% | -76.8% | +778.1% | +87.6% | +21.3% | +81.2% | -36.1% | -7.6% | +6.0% | -1.1% | +15.6% | -1.3% | +29.4% | +135.7% | -44.5% | -13.3% | +61.5% | -18.8% | -4.3% | +34.3% | +4.9% | +15.3% | -7.3% | +10.8% | -8.8% | -10.9% | +4.8% | +2.4% | -5.5% | -11.7% | -3.8% | +18.7% | -20.1% | -13.9% | +7.2% | -6.2% | – | |
| – | +18.8% | +4.5% | -22.2% | +74.5% | -8.9% | +144.1% | -52.7% | -44.7% | +26.3% | +32.9% | +15.6% | -1.5% | +14.9% | +43.8% | -4.7% | -16.1% | +43.1% | +33.1% | -12.8% | +5.3% | +21.4% | -3.3% | +9.2% | +17.5% | +26.1% | -16.9% | +9.8% | +7.0% | +15.9% | +2.8% | +23.6% | -0.9% | -6.5% | +12.3% | -12.0% | -26.7% | -20.0% | +16.2% | +2.2% | – | |
| – | +14.1% | -18.6% | -41.2% | +14.6% | -37.4% | +238.4% | +4.6% | +3.1% | +73.1% | -29.6% | -1.6% | +4.2% | +2.5% | +22.8% | -2.3% | +16.2% | +116.3% | -33.8% | -13.2% | +45.8% | -10.7% | -4.0% | +27.4% | +7.9% | +18.1% | -10.0% | +10.6% | -4.8% | -3.3% | +2.9% | +9.6% | -2.7% | -9.7% | +2.7% | +10.5% | -26.6% | -15.9% | +5.5% | +1.2% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +70.1% | -1.9% | +1.5% | +1.3% | +1.3% | +54.7% | -3.5% | -13.7% | +4.4% | +10.5% | -5.1% | -14.8% | +0.0% | +37.6% | +26.4% | +15.8% | -13.4% | -9.7% | -43.4% | +30.7% | -1.1% | -17.6% | -17.3% | -27.9% | -24.8% | +0.2% | +0.0% | +0.2% | +0.2% | +0.2% | +0.0% | +0.0% | +0.4% | -0.2% | +0.2% | +0.0% | +599.6% | -85.7% | +0.0% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +31.7% | +8.9% | +6.4% | +19.7% | +11.9% | +488.6% | -5.8% | -16.3% | +80.9% | -22.0% | +1.7% | -10.2% | -8.4% | +17.1% | +13.5% | -71.0% | -54.2% | +840.5% | -88.7% | +221.1% | +56.8% | -66.9% | -54.1% | -481.3% | – | – | – | -149.9% | – | -100.0% | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.